ArticleSpringerPlus2016

The AVOCAT study: Bicalutamide monotherapy versus combined bicalutamide plus dutasteride therapy for patients with locally advanced or metastatic carcinoma of the prostate-a long-term follow-up comparison and quality of life analysis.

Siebren Dijkstra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.